• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FIP1L1-PDGFRα阳性的慢性嗜酸性粒细胞白血病

Chronic Eosinophilic Leukemia Positive for FIP1L1-PDGFRa.

作者信息

Haydon Steven J, Ross Danielle E, Caucci Stephen, Clark Shane, Hrinczenko Borys

机构信息

Internal Medicine, Mclaren Greater Lansing, Lansing, USA.

College of Osteopathic Medicine, Michigan State University, East Lansing, USA.

出版信息

Cureus. 2025 Feb 24;17(2):e79548. doi: 10.7759/cureus.79548. eCollection 2025 Feb.

DOI:10.7759/cureus.79548
PMID:40144421
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11938322/
Abstract

positive chronic eosinophilic leukemia (CEL) is a rare subtype of myeloproliferative neoplasm characterized by organ damage caused by eosinophilic granules containing cytokines and humoral factors. These include interleukin-5 (IL-5), interleukin-4 (IL-4), and interleukin-13 (IL-13). We present a case study of a 71-year-old male who initially presented with cough, fever, night sweats, and weight loss. Fluorescence in situ hybridization (FISH) and cytogenetic testing confirmed that the patient had positive chronic eosinophilic leukemia. Treatment with imatinib and prednisone led to a rapid decrease in the eosinophil count without further damage from eosinophilic infiltration. Our patient has tolerated therapy with occasional lightheadedness that he attributed to external factors, and he continues to remain in remission. This case study aims to contribute to the existing knowledge regarding the discovery and treatment of this disease.

摘要

阳性慢性嗜酸性粒细胞白血病(CEL)是骨髓增殖性肿瘤的一种罕见亚型,其特征是由含有细胞因子和体液因子的嗜酸性粒细胞颗粒引起的器官损伤。这些因子包括白细胞介素-5(IL-5)、白细胞介素-4(IL-4)和白细胞介素-13(IL-13)。我们报告一例71岁男性病例,该患者最初表现为咳嗽、发热、盗汗和体重减轻。荧光原位杂交(FISH)和细胞遗传学检测证实该患者患有阳性慢性嗜酸性粒细胞白血病。伊马替尼和泼尼松治疗导致嗜酸性粒细胞计数迅速下降,且未因嗜酸性粒细胞浸润造成进一步损害。我们的患者耐受了治疗,偶尔出现头晕,他将其归因于外部因素,并且他仍处于缓解状态。本病例研究旨在为有关该疾病的发现和治疗的现有知识做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8b/11938322/871d0f664812/cureus-0017-00000079548-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8b/11938322/998729bfc37e/cureus-0017-00000079548-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8b/11938322/871d0f664812/cureus-0017-00000079548-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8b/11938322/998729bfc37e/cureus-0017-00000079548-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f8b/11938322/871d0f664812/cureus-0017-00000079548-i02.jpg

相似文献

1
Chronic Eosinophilic Leukemia Positive for FIP1L1-PDGFRa.FIP1L1-PDGFRα阳性的慢性嗜酸性粒细胞白血病
Cureus. 2025 Feb 24;17(2):e79548. doi: 10.7759/cureus.79548. eCollection 2025 Feb.
2
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.FIP1L1-PDFGRA(+)慢性嗜酸性粒细胞白血病的临床和分子特征
Leukemia. 2004 Apr;18(4):734-42. doi: 10.1038/sj.leu.2403313.
3
FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.单独的FIP1L1-PDGFRα或伴有其他基因异常均提示慢性嗜酸性粒细胞白血病的疾病进展,但对伊马替尼反应良好。
Chin Med J (Engl). 2008 May 20;121(10):867-73.
4
Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report.伊马替尼有效治疗伴FIP1L1/PDGFRA融合基因的血管免疫母细胞性T细胞淋巴瘤和高嗜酸性粒细胞综合征:一例报告
Medicine (Baltimore). 2017 Sep;96(36):e8001. doi: 10.1097/MD.0000000000008001.
5
Chronic eosinophilic leukemia with FIP1L1-PDGFRA transcripts after occupational and therapeutic exposure to radiation.职业性和治疗性辐射暴露后出现FIP1L1-PDGFRA转录本的慢性嗜酸性粒细胞白血病。
Hematol Rep. 2011 Aug 31;3(2):e17. doi: 10.4081/hr.2011.e17. Epub 2011 Oct 11.
6
FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib.FIP1L1-PDGFRalpha D842V,一种新型的全耐药突变体,在用单药索拉非尼治疗FIP1L1-PDGFRalpha T674I嗜酸性粒细胞白血病后出现。
Leukemia. 2009 May;23(5):845-51. doi: 10.1038/leu.2009.2. Epub 2009 Feb 12.
7
Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia followed by severe hepatotoxicity.伊马替尼成功治疗FIP1L1-PDGFRA阳性慢性嗜酸性粒细胞白血病的心脏受累,随后出现严重肝毒性。
Int J Hematol. 2007 Oct;86(3):233-7. doi: 10.1532/IJH97.07032.
8
The FIP1L1-PDGFRalpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia.高嗜酸性粒细胞综合征和慢性嗜酸性粒细胞白血病中的FIP1L1-PDGFRα激酶
Curr Opin Hematol. 2004 Jan;11(1):51-7. doi: 10.1097/00062752-200401000-00008.
9
FIP1L1-PDGFRA Clonal Hypereosinophilic Syndrome With Eosinophilic Myocarditis and Intracardiac Thrombus.伴有嗜酸性粒细胞性心肌炎和心内血栓的FIP1L1-PDGFRA克隆性嗜酸性粒细胞增多综合征
Cureus. 2023 Aug 8;15(8):e43138. doi: 10.7759/cureus.43138. eCollection 2023 Aug.
10
Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.慢性嗜酸性粒细胞白血病(CEL)伴 FIP1L1-PDGFRA 融合转录本患者的临床特征--波兰多中心研究结果。
Hematol Oncol. 2010 Jun;28(2):93-7. doi: 10.1002/hon.919.

本文引用的文献

1
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.慢性髓性白血病临床实践指南(2024 年版),NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2024 Feb;22(1):43-69. doi: 10.6004/jnccn.2024.0007.
2
How I investigate Eosinophilia.我如何研究嗜酸性粒细胞增多症。
Int J Lab Hematol. 2019 Apr;41(2):153-161. doi: 10.1111/ijlh.12955. Epub 2018 Nov 30.
3
World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.世界卫生组织定义的嗜酸性粒细胞疾病:2017 年诊断、风险分层和管理更新。
Am J Hematol. 2017 Nov;92(11):1243-1259. doi: 10.1002/ajh.24880.
4
Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing.世界卫生组织定义的高嗜酸性粒细胞综合征和特发性高嗜酸性粒细胞增多症的生存预测因素及新一代测序的作用
Leukemia. 2016 Sep;30(9):1924-6. doi: 10.1038/leu.2016.73. Epub 2016 Apr 5.
5
Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1.与 PDGFRA、PDGFRB 和 FGFR1 重排相关的血液淋巴肿瘤。
Am J Clin Pathol. 2015 Sep;144(3):377-92. doi: 10.1309/AJCPMORR5Z2IKCEM.
6
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.新型伊马替尼敏感的血小板衍生生长因子受体 A 激活点突变导致嗜酸性粒细胞增多综合征中的生长因子独立性和类白血病疾病。
Blood. 2011 Mar 10;117(10):2935-43. doi: 10.1182/blood-2010-05-286757. Epub 2011 Jan 11.
7
Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence.美国骨髓增殖性高嗜酸性粒细胞综合征的发病率及所有高嗜酸性粒细胞综合征发病率的估计值。
J Allergy Clin Immunol. 2010 Jul;126(1):179-81. doi: 10.1016/j.jaci.2010.03.035.
8
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.发现FIP1L1-PDGFRA五年以来:我们对该融合基因及其他分子定义的嗜酸性粒细胞增多症的了解
Leukemia. 2008 Nov;22(11):1999-2010. doi: 10.1038/leu.2008.287. Epub 2008 Oct 9.
9
Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome.慢性嗜酸性粒细胞白血病及高嗜酸性粒细胞综合征的骨髓增殖性变异型
Immunol Allergy Clin North Am. 2007 Aug;27(3):377-88. doi: 10.1016/j.iac.2007.06.001.
10
Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.甲磺酸伊马替尼治疗FIP1L1/PDGFRA阳性慢性嗜酸性粒细胞白血病停药后的复发:对最佳剂量的影响
Blood. 2007 Nov 15;110(10):3552-6. doi: 10.1182/blood-2007-07-100164. Epub 2007 Aug 20.